Abstract
While FDA delivers many messages to various groups, ranging from consumers to health care professionals, some risk-communication experts question the effectiveness of the agency’s efforts. “We as yet have very little information about the impact of FDA communication,” said Linda Neuhauser, a health literacy researcher at the University of California, Berkeley. She discussed the agency’s challenges during an FDA Risk Communication Advisory Committee meeting on August 14 in Rockville, Maryland. Neuhauser, who is a member of the advisory committee, said there are questions about whether traditional mass communication is the best way to deliver complicated health messages to the public. Too often, complex messages are distributed to an audience with little attention being paid to whether the key ideas are understood by the end users. She said that FDA staff take the findings, create one-way messages, and hope that the message will achieve the desired change among the intended audience.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call